financetom
Business
financetom
/
Business
/
General Motors Powers Up Diplomatic Security: Suburban Shield Heads To Qatar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
General Motors Powers Up Diplomatic Security: Suburban Shield Heads To Qatar
Jan 7, 2025 7:59 AM

General Motors Company ( GM ) shares are trading slightly lower on Tuesday in the morning session.

According to Benzinga Pro, GM stock has gained 44% in the past year. Investors can gain exposure to the stock via iShares Trust iShares U.S. Manufacturing ETF .

Today, GM Defense is making significant strides with its next-generation Suburban Shield armored vehicle. The Suburban Shield, which is designed for diplomatic security and VIP transport, will be delivered to the Qatar Armed Forces and Special Forces Command.

Read Next: Jensen Huang Unveils Monster GPUs: Nvidia’s RTX 5000 Series Starting At $549

Based on General Motors’ full-size truck and SUV platform, the vehicle incorporates advanced technologies and a unique chassis designed to meet the high-performance requirements of armored vehicles.

Unlike traditional after-market armor solutions, GM Defense integrates protective features into the original design, ensuring high levels of reliability, safety, and performance.

“We’re proud to offer this capability to the Qatar Armed Forces that will help replace their legacy platforms,” said Bradley Watters, vice president of international business development for GM Defense.

Additionally, GM Defense provides customized versions of the Suburban Shield to the U.S. Department of State’s Diplomatic Security Service for its armored SUV program.

Price Action: GM shares are trading higher by 1.66% to $52.64 at last check Tuesday.

Read More:

JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved